Neuropsychological Features of Asymptomatic c.709-1G>A Progranulin Mutation Carriers

被引:20
|
作者
Barandiaran, Myriam [1 ,2 ,3 ]
Estanga, Ainara [2 ,3 ,4 ]
Moreno, Fermin [1 ,2 ,3 ,4 ]
Indakoetxea, Begona [1 ,2 ,3 ,4 ]
Alzualde, Ainhoa [2 ,3 ,4 ]
Balluerka, Nekane [5 ]
Marti Masso, Jose Felix [1 ,2 ,3 ,4 ]
Lopez de Munain, Adolfo [1 ,2 ,3 ,4 ]
机构
[1] Hosp Donostia, Dept Neurol, San Sebastian 20014, Gipuzkoa, Spain
[2] Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Area 6, Gipuzkoa, Spain
[3] Ilundain Fundazioa, Neurogenet Res Unit, Gipuzkoa, Spain
[4] Inst Biodonostia, Neurociences Area, San Sebastian, Gipuzkoa, Spain
[5] Univ Basque Country, Dept Social Psychol & Methodol Behav Sci, San Sebastian, Spain
关键词
Frontotemporal dementia; Cognition; Executive function; Attention; Primary progressive aphasia; Early diagnosis; FRONTOTEMPORAL DEMENTIA; GENE;
D O I
10.1017/S1355617712000823
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the progranulin (PGRN) gene have been identified as a cause of frontotemporal dementia (FTD). However, little is known about the neuropsychological abilities of asymptomatic carriers of these mutations. The aim of the study was to assess cognitive functioning in asymptomatic c.709-1G>A PGRN mutation carriers. We hypothesized that poorer neuropsychological performance could be present before the development of clinically significant FTD symptoms. Thirty-two asymptomatic first-degree relatives of FTD patients carrying the c.709-1G>A mutation served as study participants, including 13 PGRN mutation carriers (A-PGRN+) and 19 non-carriers (PGRN-). A neuropsychological battery was administered. We found that the A-PGRN+ participants obtained significantly poorer scores than PGRN- individuals on tests of attention (Trail-Making Test Part A), mental flexibility (Trail-Making Test Part B), and language (Boston Naming Test). Poorer performance on these tests in asymptomatic PGRN mutation carriers may reflect a prodromal phase preceding the onset of clinically significant symptoms of FTD. (JINS, 2012, 18, 1086-1090)
引用
收藏
页码:1086 / 1090
页数:5
相关论文
共 50 条
  • [21] Fear of disease progression in carriers of the m.3243A>G mutation
    Custers, Jose A. E.
    de Laat, Paul
    Koene, Saskia
    Smeitink, Jan
    Janssen, Mirian C. H.
    Verhaak, Christianne
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [22] BRCA1 c.4987-3C>G is a pathogenic mutation
    Brandao, Rita D.
    van Roozendaal, Kees E. P.
    Tserpelis, Demis
    Caanen, Beppy
    Garcia, Encarna Gomez
    Blok, Marinus J.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 723 - 725
  • [23] Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers
    Vucic, Steve
    Winhammar, Jennica M. C.
    Rowe, Dominic B.
    Kiernan, Matthew C.
    CLINICAL NEUROPHYSIOLOGY, 2010, 121 (10) : 1781 - 1785
  • [24] Prolonged Pursuit by Optokinetic Drum Testing in Asymptomatic Female Carriers of Novel FRMD7 Splice Mutation c. 1050+5 G>A
    Khan, Arif O.
    Shinwari, Jameela
    Al-Sharif, Latifa
    Khalil, Dania S.
    Al Tassan, Nada
    ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (07) : 936 - 940
  • [25] Clinical features of the c.1858G>A mutation in VPS35-associated parkinsonism
    Weissbach, A.
    Kumar, K. R.
    Heldmann, M.
    Kasten, M.
    Tunc, S.
    Sue, C. M.
    Vieregge, P.
    Muente, T. F.
    Lohmann, K.
    Klein, C.
    Hagenah, J.
    MOVEMENT DISORDERS, 2012, 27 : S145 - S146
  • [26] Phenotypic and muscle biopsy features of patients with FKRP c.1387A>G founder mutation
    Lee, Angela
    Jones, Karra
    Mathews, Katherine
    Moore, Steven
    Butterfield, Russell
    Johnson, Nicholas
    Konersman, Chamindra
    Abdenur, Jose
    Beson, Brent
    NEUROLOGY, 2018, 90
  • [27] Similar findings on clinical and neuropsychological measures in asymptomatic mutation versus non-mutation carriers: preliminary data from LEFFTDS
    Boeve, B.
    Rosen, H.
    Boxer, A.
    Coppola, G.
    Dheel, C.
    Dickerson, B.
    Faber, K.
    Fields, J.
    Foroud, T.
    Gavrilova, R.
    Ghoshal, N.
    Goldman, J.
    Graff-Radford, N.
    Grossman, M.
    Heuer, H.
    Hsiao, J.
    Hsiung, R.
    Huey, E.
    Irwin, D.
    Kantarci, K.
    Karydas, A.
    Knopman, D.
    Kornak, J.
    Kramer, J.
    Kukull, W.
    Mackenzie, I.
    Miller, B.
    Phelps, C.
    Rademakers, R.
    Rankin, K.
    Shaw, L.
    Sutherland, M.
    Toga, A.
    Trojanowski, J.
    Vetor, A.
    Weintraub, S.
    Wszolek, Z.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 287 - 287
  • [28] A Uniquely Mild Presentation of Hyperinsulinemic Hypoglycemia Due to a HADH Mutation (c.709+39C>G) Not Treated with Diazoxide: Long Term Clinical Course
    Abdulhadi-Atwan, Maha
    Flanagan, Sarah
    Houghton, Jayne
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 260 - 260
  • [29] Evidence of early cardiac impairment in m.3243A>G mutation carriers
    Bates, M. G.
    Hollingsworth, K. G.
    Newman, J.
    Jakovljevic, D.
    Dixon, B. J.
    Blamire, A. M.
    MacGowan, G. A.
    Keavney, B. D.
    Chinnery, P. F.
    Turnbull, D. M.
    Taylor, R. W.
    Trenell, M. I.
    Gorman, G. S.
    NEUROMUSCULAR DISORDERS, 2012, 22 : S22 - S23
  • [30] Autonomic Symptoms in Carriers of the m.3243A>G Mitochondrial DNA Mutation
    Parsons, Timothy
    Weimer, Louis
    Engelstad, Kristin
    Linker, Alex
    Battista, Vanessa
    Wei, Ying
    Hirano, Michio
    DiMauro, Salvatore
    De Vivo, Darryl C.
    Kaufmann, Petra
    ARCHIVES OF NEUROLOGY, 2010, 67 (08) : 976 - 979